Health & Fitness
Health and Fitness
Health and Fitness
Thu, November 19, 2009
Wed, November 18, 2009
Tue, November 17, 2009 
HIGH SPRINGS, FL--(Marketwire - November 17, 2009) - CTD Holdings, Inc. ( ViStra is a consulting company providing corporate planning and strategic growth strategies for private, start-up and micro-cap public companies. ViStra provides its clients with consulting services relating to business structure, organizational management, capital procurement, accessing public capital markets, strategic acquisitions and investor communications. ViStra intends to focus its full suite of services in support of clients' needs, which are primarily privately held corporations and start-ups. In addition, the company believes that it can deliver a complete solution of communication services to meet the needs of all areas of a publicly traded company. Mr. Louis Weltman will be Chief Executive Officer of ViStra and will be responsible for its operations. He brings corporate strategy, structured financing, and property development expertise to CTD and ViStra's clients. Mr. Strattan, Chief Executive of CTD Holdings, the parent company of ViStra, stated, "We are excited about the opportunities that ViStra, with the strong direction of Mr. Weltman, will create for CTD as it begins to expand its business plan and corporate opportunities. I am extremely confident that Mr. Weltman's experience in the private and public company universe will enhance CTD's and ViStra's clients exposure to the public capital markets." Mr. Weltman graduated from the Wharton Business School and obtained his MBA from The Stern School at New York University. His experience includes consulting or ownership of public and private companies; management of a variety of businesses including home furnishings and printing companies and he has founded or was CEO of a range of companies. About CTD Holdings, Inc. The company is the one-stop shop, business-to-business facilitator of commercial and research applications of Cyclodextrins. With its branded Trappsol®, Aquaplex® and Cyclo™ product offerings, CTDH scientists coordinate the development of commercial products for use in the pharmaceuticals, foods, hazardous waste treatment, and cosmetics industries, which endeavor to put non water-soluble ingredients into water-based formulations. More recently CTDH has worked, in an advisory capacity, on the benefits and application of Cyclodextrins as a treatment for Neimann Pick C disease, a debilitating childhood disease often called Childhood Alzheimer's. More information about the company is available on the company's website: [ www.cyclodex.com ] This news release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements. CTDH complies with the regulations and time lines mandated by the SEC in the filing of its financial reports; these filings also contain forward-looking statements. The above forward-looking statements are made as of the date above; CTD Holdings, Inc accepts no specific responsibility for updating such statements.
